Research Article

Effects of Qigong Training on Health-Related Quality of Life, Functioning, and Cancer-Related Symptoms in Survivors of Nasopharyngeal Cancer: A Pilot Study

Table 3

EORTC scores measured at four time points.

Qigong group ( )Control group ( ) Group × time interaction Group effect Time effect
Pre MidPost FU Pre MidPost FU Effect size Effect size Effect size

EORTC QLQ-C30
Global health status/QOL61.81 ± 22.1063.19 ± 24.3261.81 ± 26.5766.67 ± 27.4758.65 ± 21.0162.50 ± 18.3066.03 ± 18.55a67.95 ± 16.45a0.1430.067<0.0010.9450.2130.011*
Functional scales (higher scores = higher functions)0.3870.1890.1430.2210.4100.134
 Physical functioning78.06 ± 16.8580.56 ± 15.2279.17 ± 13.9478.89 ± 15.0676.67 ± 13.1078.72 ± 12.2277.18 ± 12.5377.44 ± 13.21
 Role functioning80.56 ± 22.8881.25 ± 21.0384.03 ± 21.6986.11 ± 21.8087.18 ± 19.0486.54 ± 18.2785.90 ± 18.0784.62 ± 21.56
 Emotional
 functioning
76.74 ± 19.1979.51 ± 19.3578.13 ± 20.2481.60 ± 18.3977.24 ± 20.3576.28 ± 18.9678.53 ± 19.3280.45 ± 18.40
 Cognitive
 functioning
65.97 ± 23.3065.28 ± 20.2168.75 ± 24.2369.44 ± 21.2369.23 ± 24.8167.95 ± 26.6372.44 ± 22.5869.87 ± 24.50
 Social functioning74.31 ± 25.5375.69 ± 26.0077.08 ± 27.7279.86 ± 26.4686.54 ± 18.8787.18 ± 17.2085.90 ± 16.1283.33 ± 17.00
Symptom scales (higher scores = more symptoms)0.6670.1230.1900.4250.6590.140
 Fatigue37.50 ± 20.6736.11 ± 18.8934.72 ± 20.5433.80 ± 21.8535.47 ± 18.0634.19 ± 17.7638.03 ± 17.2635.47 ± 19.88
 Nausea and vomiting6.94 ± 12.935.56 ± 11.704.17 ± 10.134.17 ± 10.135.13 ± 11.325.13 ± 11.325.13 ± 11.325.77 ± 11.49
 Pain32.64 ± 24.8131.94 ± 23.0129.86 ± 24.0725.69 ± 24.5625.64 ± 20.1324.36 ± 19.5726.92 ± 18.9027.56 ± 18.82
 Dyspnea31.94 ± 25.0229.17 ± 20.4123.61 ± 20.8023.61 ± 20.8026.92 ± 24.9823.08 ± 20.5924.36 ± 22.2325.64 ± 21.72
 Insomnia29.17 ± 22.6627.78 ± 27.2226.39 ± 25.9720.83 ± 21.5634.62 ± 30.5233.33 ± 31.2743.59 ± 32.3442.31 ± 34.71
 Appetite loss25.00 ± 28.2322.22 ± 28.9418.06 ± 25.9715.28 ± 25.9712.82 ± 19.0414.10 ± 21.4415.38 ± 23.5312.82 ± 23.24
 Constipation15.28 ± 21.9320.83 ± 23.7019.44 ± 27.6615.28 ± 24.0421.79 ± 22.9817.95 ± 19.3917.95 ± 21.5614.10 ± 19.26
 Diarrhea15.28 ± 19.618.33 ± 14.749.72 ± 18.3312.50 ± 19.1912.82 ± 19.0414.10 ± 19.2614.10 ± 21.4411.54 ± 18.72
 Financial difficulties26.39 ± 31.0526.39 ± 32.5720.83 ± 33.7819.44 ± 32.4812.82 ± 19.0414.10 ± 19.2615.38 ± 16.9517.95 ± 19.39

EORTC QLQ-H&N35
Symptom scales (higher scores = more symptoms)0.8040.3170.5720.003*0.8040.317
 Pain12.68 ± 13.0212.68 ± 13.7314.13 ± 16.9410.87 ± 12.6717.75 ± 24.2719.20 ± 17.8419.20 ± 16.5618.48 ± 16.47
 Swallowing34.03 ± 25.0531.94 ± 26.6634.38 ± 25.8134.72 ± 24.9029.32 ± 18.6928.70 ± 17.9528.09 ± 17.0126.23 ± 16.13
 Sense problems22.22 ± 18.8221.53 ± 17.36b18.75 ± 17.93b16.67 ± 14.74b33.95 ± 28.6735.80 ± 26.0334.57 ± 26.5233.95 ± 25.94
 Speech problems29.17 ± 24.9128.24 ± 25.38b27.78 ± 25.80b23.61 ± 23.4718.52 ± 22.8514.81 ± 19.4913.99 ± 19.1412.76 ± 18.92
 Trouble with social
 eating
39.24 ± 32.3736.81 ± 31.9435.07 ± 33.2433.33 ± 32.8827.78 ± 29.8725.93 ± 25.0427.47 ± 24.1125.62 ± 24.88
 Trouble with social
 contact
21.45 ± 24.3719.13 ± 21.4018.84 ± 23.3216.81 ± 22.6412.46 ± 20.0313.33 ± 19.079.28 ± 18.839.57 ± 19.47
 Less sexuality 39.86 ± 33.9936.23 ± 30.8434.06 ± 30.7639.86 ± 34.3635.51 ± 29.8642.03 ± 30.5146.38 ± 34.0746.38 ± 34.07
 Teeth44.44 ± 27.2238.89 ± 23.4037.50 ± 28.3438.89 ± 27.2239.51 ± 30.7134.57 ± 31.3338.27 ± 32.9543.21 ± 33.10
 Opening mouth36.11 ± 30.9530.56 ± 30.9533.33 ± 31.0831.94 ± 30.2628.40 ± 30.2532.10 ± 32.6634.57 ± 32.6632.10 ± 29.93
 Dry mouth65.28 ± 25.0256.94 ± 23.0155.56 ± 23.4055.56 ± 23.4062.96 ± 29.7261.73 ± 28.8062.96 ± 28.2456.79 ± 30.40
 Sticky saliva44.44 ± 32.1038.89 ± 30.5638.89 ± 30.5638.89 ± 30.5648.15 ± 36.2050.62 ± 35.0550.62 ± 28.3050.62 ± 31.17
 Coughing25.00 ± 22.5223.61 ± 23.0125.00 ± 24.5725.00 ± 24.5729.63 ± 31.1219.75 ± 24.9117.28 ± 16.9718.52 ± 19.25
Felt ill33.33 ± 20.6028.99 ± 25.2324.64 ± 27.0024.64 ± 25.0630.43 ± 28.2731.88 ± 30.9436.23 ± 28.2733.33 ± 22.47

Pre: pretest (baseline); mid: midintervention test (3 months); post: posttest (6 months); FU: follow-up test (12 months).
Mean ± SD presented the continuous variables.
The effect sizes are in partial eta-squared.
Group-by-time interaction, group and time effects.
*Significant difference at .
Within group (alpha adjusted to 0.008 due to six paired comparisons).
aSignificant difference at compared with the pretest values.
Between groups.
bDifference significant at compared with the control group.